Triple therapy or etanercept after methotrexate failure in RA?

被引：0

作者：

Ronald F. van Vollenhoven

Katerina Chatzidionysiou

机构：

[1] Unit for Clinical Therapy Research,

[2] Inflammatory Diseases,undefined

[3] The Karolinska Institute,undefined

[4] Karolinska University Hospital,undefined

[5] D1:00,undefined

来源：

Nature Reviews Rheumatology | 2013年 / 9卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Since the 1990s, patients with rheumatoid arthritis have been treated with at least one DMARD. Methotrexate, which is usually the first-line treatment, elicits good or even excellent clinical results in 20–30% of patients—but in most patients it does not. Thus, an important question is what to do after methotrexate failure.

引用

页码：510 / 512

页数：2

共 50 条

[1] RHEUMATOID ARTHRITIS Triple therapy or etanercept after methotrexate failure in RA?
van Vollenhoven, Ronald F.
Chatzidionysiou, Katerina
NATURE REVIEWS RHEUMATOLOGY, 2013, 9 (09) : 510 - 512
[2] Rheumatoid Arthritis Treatment After Methotrexate: The Durability of Triple Therapy Versus Etanercept
Peper, Shana M.
Lew, Robert
Mikuls, Ted
Brophy, Mary
Rybin, Denis
Wu, Hongseng
O'Dell, James
ARTHRITIS CARE & RESEARCH, 2017, 69 (10) : 1467 - 1472
[3] Etanercept and methotrexate combination therapy
Bankhurst, AD
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1999, 17 (06) : S69 - S72
[4] Efficacy of triple DMARD therapy in patients with RA with suboptimal response to methotrexate
ODell, JR
Haire, C
Erikson, N
Drymalski, W
Palmer, W
Maloley, P
Klassen, LW
Wees, S
Moore, GF
JOURNAL OF RHEUMATOLOGY, 1996, 23 : 72 - 74
[5] EVALUATION OF BIOLOGIC THERAPY VERSUS TRIPLE DMARD THERAPY IN RA PATIENTS UNRESPONSIVE TO METHOTREXATE
Vernice, Nicholas A.
Reiss, Allison B.
Renna, Heather A.
DeLeon, Joshua
Carsons, Steven
Kasselman, Lora J.
JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (03) : 697 - 697
[6] Oropharyngeal carcinoma arising after methotrexate and etanercept therapy for rheumatoid arthritis
Chainani-Wu, Nita
Chang, Crystal
Gross, A. J.
Yom, S. S.
Silverman, Sol, Jr.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2014, 117 (03): : E261 - E263
[7] The Canadian Methotrexate and Etanercept Outcome Study: a randomised trial of discontinuing versus continuing methotrexate after 6 months of etanercept and methotrexate therapy in rheumatoid arthritis
Pope, Janet E.
Haraoui, Boulos
Thorne, J. Carter
Vieira, Andrew
Poulin-Costello, Melanie
Keystone, Edward C.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (12) : 2144 - 2151
[8] BUDGET IMPACT ANALYSIS OF TRIPLE THERAPY AFTER FAILURE OF METHOTREXATE FOR THE TREATMENT OF RHEUMATOID ARTHRITIS IN FRANCE
Scarica, R.
Darlington, M.
Wali, A.
Durand-Zaleski, I
VALUE IN HEALTH, 2019, 22 : S700 - S700
[9] Etanercept or DMARDs for RA combination therapy?
Nature Reviews Rheumatology, 2014, 10 (8) : 444 - 444
[10] Etanercept/methotrexate/tocilizumabTreatment failure: case report
Reactions Weekly, 2022, 1936 (1) : 219 - 219

← 1 2 3 4 5 →